Log in

Relevant bibliographies by topics / Heparin Therapeutic use / Books

Books on the topic 'Heparin Therapeutic use'

To see the other types of publications on this topic, follow the link: Heparin Therapeutic use.

Author: Grafiati

Published: 10 December 2022

Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 42 books for your research on the topic 'Heparin Therapeutic use.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Barrowcliffe, Trevor W. Low molecular weight heparin. Chichester, West Sussex, England: Wiley, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kovaliv, Bohdan. Heparyn i heparynoïdy y klinichniĭ praktyt͡s︡i. Lʹviv: Lʹvivsʹkyĭ derz͡h︡avnyĭ medychnyĭ universytet im. Danyla Halyt͡s︡koho, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Warkentin, Theodore E., and Andreas Greinacher. Heparin-induced thrombocytopenia. 4th ed. New York: Informa Healthcare, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

1960-, Warkentin Theodore E., and Greinacher Andreas, eds. Heparin-induced thrombocytopenia. 4th ed. New York: Informa Healthcare USA, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Khaliq, Yasmin. Clinical significance of the nitroglycerin-heparin interaction. [Ottawa, Ont.?: s.n.], 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

1960-, Warkentin Theodore E., and Greinacher Andreas, eds. Heparin-induced thrombocytopenia. 2nd ed. New York: Dekker, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

1960-, Warkentin Theodore E., and Greinacher Andreas, eds. Heparin-induced thrombocytopenia. 3rd ed. New York: Marcel Dekker, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Thromoprophylaxis with low-molecular-weight heparins. London: Current Medicine Group, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

1940-, Kher André, Sarret Monique 1938-, and Toulemonde Francis 1926-, eds. Low molecular weight heparin therapy: An evaluation of clinical trials evidence. New York: Marcel Dekker, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Heparin and the prevention of atherosclerosis: Basic research and clinical application. New York: Wiley-Liss, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Shukla, Vijay K. Low molecular weight heparins for major orthopedic surgery: A case for clinical outcomes. Ottawa, Ont: Canadian Coordinating Office for Health Technology Assessment, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Parker, James N., and Philip M. Parker. Enoxaparin: A medical dictionary, bibliography, and annotated research guide to Internet references. San Diego, CA: ICON Health Publications, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

A, Mousa Shaker, ed. Anticoagulants, antiplatelets, and thrombolytics. Totowa, N.J: Humana Press, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Anticoagulants, antiplatelets, and thrombolytics. 2nd ed. New York, NY: Humana, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

1960-, Warkentin Theodore E., and Greinacher Andreas, eds. Heparin-induced thrombocytopenia. New York: Dekker, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

H, Bounameaux, Cate J. W. ten, and Samama Meyer M, eds. Fraxiparine: Second international symposium : recent pharmacological and clinical data. Stuttgart: Schattauer, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Warkentin, Theodore E., and Andreas Greinacher. Heparin-Induced Thrombocytopenia. Taylor & Francis Group, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Low Molecular Weight Haparins. 3rd ed. BC Decker Inc., 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Low-molecular-weight heparins in prophylaxis and therapy of thromboembolic diseases. New York: M. Dekker, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Heparin-Induced Thrombocytopenia, Fourth Edition (Fundamental and Clinical Cardiology). 4th ed. Informa Healthcare, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Madison, Rick Alan. A survey of current nursing practices surrounding low-dose heparin administration and site selection. 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

1968-, Oremus Mark, United States. Agency for Healthcare Research and Quality., and McMaster University. Evidence-based Practice Center., eds. The uses of heparin to treat burn injury. Rockville, MD: AHRQ, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

The uses of heparin to treat burn injury. Rockville, MD: AHRQ, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Christian, Doutremepuich, ed. Low molecular weight heparins in clinical practice. New York: Dekker, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Sharnoff, J. G. Prevention of Venous Thrombosis and Pulmonary Embolism. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Sharnoff, J. G. Prevention of Venous Thrombosis and Pulmonary Embolism. Springer London, Limited, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Publications, ICON Health. Heparin - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Valentin, Fuster, and Verstraete M, eds. Thrombosis in cardiovascular disorders. Philadelphia: Saunders, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Thrombosis in cardiovascular diseases. Philadelphia: Saunders, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Schulman, Sam, Benjamin Brenner, Gilles Lugassy, Meyer Samama, and Marc Cohen. Thrombosis Antithrombotic Therapy. Informa Healthcare, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Khorana, Alok A., and Charles W. Francis. Cancer-Associated Thrombosis: New Findings in Translational Science, Prevention, and Treatment. Taylor & Francis Group, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Khorana, Alok A., and Charles W. Francis. Cancer-Associated Thrombosis: New Findings in Translational Science, Prevention, and Treatment. Taylor & Francis Group, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

(Editor), Alok A. Khorana, and Charles W. Francis (Editor), eds. Cancer-Associated Thrombosis: New Findings in Translational Science, Prevention, and Treatment. Informa Healthcare, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Anticoagulants, antiplatelets, and thrombolytics. Totowa, NJ: Humana Press, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Mousa, Shaker A. Anticoagulants, Antiplatelets, and Thrombolytics (Methods in Molecular Medicine). Humana Press, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

A, Mousa Shaker, ed. Anticoagulants, antiplatelets, and thrombolytics. Totowa, N.J: Humana Press, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Hepatic encephalopathy: Syndromes and therapies. Bloomington, Ill: Medi-Ed Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Conn, Harold O. Hepatic Encephalopathy: Syndromes and Therapies. Medi-ed Pr, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Conn, Harold O. Hepatic Encephalopathy: Management With Lactulose and Related Carbohydrates. Medi-ed Pr, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Hepatic encephalopathy: Management with lactulose and related carbohydrates. East Lansing, Mich: Medi-Ed Press, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Capodanno, Davide. Bivalirudin and argatroban. Edited by Raffaele DeCaterina. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198784906.003.0052.

Full text

Abstract:

The central role of thrombin in the process of clot formation makes it an important therapeutic target. Heparin is a potent anticoagulant, but has a number of limitations, in that—for example—it does not bind clot-bound thrombin, activates platelets, and may determine heparin-induced thrombocytopenia (HIT). Bivalirudin and argatroban, which belong to the class of intravenous direct thrombin inhibitors, overcome many of the limitations of heparin. Bivalirudin is currently indicated for patients undergoing percutaneous coronary intervention, patients with non-ST-segment elevation acute coronary syndromes planned for urgent or early intervention, and patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Both argatroban and bivalirudin can be used as an alternative to heparin in patients with HIT and HIT-thrombosis syndrome. This chapter describes the current clinical applications of bivalirudin and argatroban.

APA, Harvard, Vancouver, ISO, and other styles

42

Rosenblatt, Elizabeth. Peritonitis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0032.

Full text

Abstract:

Peritonitis, or inflammation of the serosal membranes lining the abdominal cavity, is used predominately to describe primary peritonitis (spontaneous bacterial peritonitis [SBP]) and secondary peritonitis—two conditions with distinct pathophysiologies that require different diagnostic and therapeutic approaches. Tertiary peritonitis is characterized by persistent symptoms or signs of infection despite appropriate treatment of primary or secondary peritonitis. Patients undergoing peritoneal dialysis are at risk for catheter-associated peritonitis, which is sometimes considered an additional category of peritonitis. The most common manifestation of SBP is fever. In addition, patients often endure abdominal pain, general malaise, fatigue, and hepatic encephalopathy. One-third of patients with SBP develop renal dysfunction, which is an independent predictor of mortality. In patients with ascites and high clinical suspicion for infection, empiric antibiotic therapy should be started immediately following blood cultures and diagnostic paracentesis.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!